Gracell Biotechnologies Inc.: operating_income
| Value | {"unit": "CNY", "value": -62504000, "concept": "us-gaap:OperatingIncomeLoss"} |
|---|---|
| Period | 2018-01-01 – 2018-12-31 |
| Status | current |
| Entity | Gracell Biotechnologies Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/df588a0e-9257-47c1-9813-56b7ebc2b2c8
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-21-128979Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001826492/operating-income/2018-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/df588a0e-9257-47c1-9813-56b7ebc2b2c8
History
- no predecessors — first report